Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19Neoplasms 12Colorectal Neoplasms 5Pain, Postoperative 4Fatigue 4Thyroid Neoplasms 3Stomatitis 3Pain 3Malnutrition 3Liver Neoplasms 3Depression 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Stomach Neoplasms 2Sleep Initiation and Maintenance Disorders 2Polycystic Ovary Syndrome 2Parasomnias 2Motor Activity 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Cancer Female 2Agnosia 2Weight Loss 1Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Incontinence 1Unilateral U/S PVB 1Ulcer 1

Interventions

Electrocardiography 3Echocardiography 3Surveys and Questionnaires 2Nutrition Assessment 2Carvedilol 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1candesartan 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sodium Chloride 1Simendan 1Sevelamer 1Rocuronium 1Resistance Training 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Palliative Care 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Metoprolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Heart Failure × Control Groups × Clear all
NCT03557255 2018-06-14

Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡